Developing three novel small-molecule drugs with unique mechanisms of action to transform the treatment landscape for obsessive-compulsive disorder (OCD), a debilitating mental illness affecting millions worldwide.
Learn About Our Approach
News and Awards
Contact Us
Learn About Our Approach
News and Awards
Contact Us
Location: United Kingdom